Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 328 entries
View as:

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004124 Org: User:
Start: 10/15/99 End: 05/01/18 Due: 05/01/19

S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx

Phase: N/A Priority: Normal
NCT ID: NCT00003040 Org: User:
Start: 09/30/97 End: 12/31/07 Due: 12/31/08

S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00049179 Org: User:
Start: 04/30/03 End: 10/31/10 Due: 10/31/11

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00005090 Org: User:
Start: 04/30/00 End: 05/31/05 Due: 05/31/06

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00872989 Org: User:
Start: 03/31/10 End: 05/31/14 Due: 05/31/15

Arsenic Trioxide in Treating Men With Germ Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00036842 Org: User:
Start: 04/30/02 End: 06/30/07 Due: 06/30/08

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00016419 Org: User:
Start: 08/31/01 End: 01/31/07 Due: 01/31/08

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT01416688 Org: User:
Start: 11/15/11 End: 04/08/19 Due: 04/08/20

S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01575535 Org: User:
Start: 04/30/12 End: 05/31/12 Due: 05/31/13

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002920 Org: User:
Start: 03/31/97 End: 12/31/09 Due: 12/31/10

S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

Phase: N/A Priority: Normal
NCT ID: NCT00086996 Org: User:
Start: 09/30/04 End: 08/31/11 Due: 08/31/12

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03373760 Org: User:
Start: 11/30/17 End: 03/29/22 Due: 03/29/23

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03418961 Org: User:
Start: 11/01/17 End: 09/15/27 Due: 09/15/28

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01674140 Org: User:
Start: 09/12/13 End: 01/31/30 Due: 01/31/31

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03365882 Org: User:
Start: 11/27/17 End: 11/30/25 Due: 11/30/26

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Phase: N/A Priority: Normal
NCT ID: NCT00898066 Org: User:
Start: 09/30/05 End: 06/30/07 Due: 06/30/08

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00217659 Org: User:
Start: 09/30/05 End: 01/31/07 Due: 01/31/08

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00104988 Org: User:
Start: 06/30/05 End: 08/31/09 Due: 08/31/10

S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed

Phase: N/A Priority: Normal
NCT ID: NCT00002593 Org: User:
Start: 12/31/94 End: 03/31/05 Due: 03/31/06

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00066612 Org: User:
Start: 07/31/03 End: 05/31/10 Due: 05/31/11

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05929768 Org: User:
Start: 09/15/23 End: 04/30/33 Due: 04/30/34

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00900042 Org: User:
Start: 07/31/93 End: 01/31/03 Due: 01/31/04

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Phase: N/A Priority: Normal
NCT ID: NCT04071457 Org: User:
Start: 08/13/19 End: 07/01/40 Due: 07/01/41

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01498289 Org: User:
Start: 02/29/12 End: 09/19/19 Due: 09/19/20

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06031688 Org: User:
Start: 08/08/24 End: 05/31/29 Due: 05/31/30